News

Public · Published

Pfizer Reports Q3 Revenue of $16.6 Billion, Raises 2026 Guidance

Pfizer reported third-quarter 2026 revenue of $16.6 billion, relatively flat year over year, with adjusted diluted EPS of $0.87. It raised full-year 2026 revenue guidance to $62.0 billion–$64.0 billion and adjusted EPS guidance to $2.95–$3.05, while reported net income was $3.2 billion.

Published:

Updated:

What happened

Pfizer reported third-quarter 2026 revenue of $16.6 billion, relatively flat year over year, with adjusted diluted EPS of $0.87. It raised full-year 2026 revenue guidance to $62.0 billion–$64.0 billion and adjusted EPS guidance to $2.95–$3.05, while reported net income was $3.2 billion.

Confirmed

Global impact / market context

The guidance raise signals management expects stronger cash flow ahead, even though headline revenue was flat. Investors should note growth came from newer products while older vaccines and treatments shrank, which shifts Pfizer's revenue mix and may change how durable future profits look.

Analyst inference

Pfizer's results show a company replacing falling sales of older products with newer launches and acquisitions. The higher guidance suggests cost and revenue trends are improving, but the 8% net income decline shows reported profit still faces pressure that investors will weigh against the brighter outlook.

Analyst inference

What to watch

  1. Excluding Comirnaty and Paxlovid, third-quarter revenue grew 7% operationally, while launched and acquired products grew 32% operationally, showing where Pfizer's growth is coming from. Confirmed
  2. Pfizer's pipeline progress, including a positive Phase 3 interim readout for Elrexfio and Phase 3 results for Litfulo, could support future revenue if late-stage studies and regulatory reviews succeed. Proposed
  3. Watch whether lower demand for Paxlovid, Comirnaty and the Prevnar family keeps offsetting newer product gains, since that mix decides whether the raised 2026 guidance is met. Analyst inference

Evidence

  • Original source link unavailable